Markers of immune activation and inflammation at baseline.
收藏NIAID Data Ecosystem2026-03-06 收录
数据链接：
官方服务：
资源简介：
IQR, interquartile range (25th–75th percentile); MVC, maraviroc; EFV, efavirenz; ZDV/3TC, zidovudine/lamivudine.
应用场景：
创建时间：
2010-10-06
相关数据集
ATN015 HIV Related Diagnosis Form [CRF 2A] Dataset in Short-Cycle Therapy in Adolescents Following Continuous Therapy with Established Viral Suppression: The Impact on Viral Load Suppression
Data from HIV Related Diagnosis Form [CRF 2A] Study Description A prospective proof of concept study of subjects who had successfully suppressed their HIV-1 RNA levels for a minimum of 6 months prior
NIAID Data Ecosystem80
SUPPORTING INFORMATION: IFPTML Multi-output Modelling for Anti-Retroviral Compounds Including Drug Structure and Target Protein Sequences Information
Documents SI01: Table S1. Dataset used and results of the MMA model, including compound code, molecular descriptors, and conditions of assay was delivered in the file – SI01.xlsxSI02: Table S2.
DataCite Commons2025-04-08 更新70
ATN 061 Chemistry Results Primary Dataset in Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATV/r) in Adolescents and Young Adults with CD4 + T Cells > 350 cells/mm3 Initiating HAART
Data from Chemistry Results Form [CRF 11, questions 1-2, 3-4, 5, and 6 and 6a for version 1] Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years wit
NIAID Data Ecosystem40
ATN 024 Antiretroviral Medications: Other Antiretroviral Medication Listing [CRF 4] Dataset in A Randomized, Open-Label Trial of Three Hepatitis B Vaccination Schemas in HIV-Positive Youth
Data from Antiretroviral Medications Form: Other Antiretroviral Medication Listing [CRF 4] Study Description Suboptimal response to hepatitis B vaccination in HIV-positive adults and children has been
NIAID Data Ecosystem70
ATN 061 CDC Classification Dataset in Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/ritonavir (ATV/r) in Adolescents and Young Adults with CD4 + T Cells > 350 cells/mm3 Initiating HAART
Data from HIV and Non-HIV Diagnoses Form [CRF 5, questions 2-3] Study Description A randomized, proof-of-concept study of adolescents and young adults aged 18-24 years with confirmed HIV acquired afte
NIAID Data Ecosystem60
